Its cognition-enhancing effects may be due to an ability to influence the brains levels of noradrenaline, serotonin, and dopamine,4 three neurotransmitters with well-documented relationships to vigilance, attention, learning,5 memory,6 and the motivation toward cognitive effort.7 Meanwhile, its anxiolytic effects appear to be GABAergic (i.e., relating to the neurotransmitter GABA)
Introduction Interstitial cystitis/Painful bladder syndrome (IC/PBS) is chronic discomfort of the bladder wall, presenting with symptoms such as urinary frequency, urgency, and severe pelvic or suprapubic pain
Why retatrutide storage matters more than you think Peptides are not like most medications sitting in your medicine cabinet
Acknowledgements We thank Professor Bart De Strooper (VIB Center for Brain and Disease Research, Leuven, Belgium
The peptides under consideration this week are: BPC-157, proposed for treating ulcerative colitis KPV for wound healing and inflammatory conditions TB-500 for wound healing MOTs-C for obesity and osteoporosis Emideltide for opioid withdrawal, chronic insomnia and narcolepsy Semax for certain neurological disorders Epitalon for insomnia The FDA advisory committee will be determining whether or not it will allow access to these substances through legitimate state-licensed compounding pharmacies, said Scott Brunner, chief executive officer of the Alliance for Pharmacy Compounding, who sent a public letter to the committee in support of adding peptides to the list
And the legal pathway is still unresolved as of this writing, with the pivotal July 2026 FDA advisory hearing still ahead